BridgeBio Oncology Therapeutics (BBOT)

BridgeBio Oncology Therapeutics (BBOT)

BridgeBio Oncology Therapeutics (BBOT) is a clinical-stage biopharmaceutical company advancing a next generation pipeline of novel small molecule therapeutics targeting RAS and PI3K malignancies. Initially formed as a subsidiary of BridgeBio Services, BBOT completed a $200M private financing with external investors in 2024 with the goal of improving outcomes for patients with cancers driven by the two most prevalent oncogenes in human tumors. 

For more information visit bridgebiooncology.com.

Vagas abertas
1
ativas agora
Novas hoje
0
últimas 24 horas
Remoto global
0
de qualquer lugar
Departamentos
1
contratando em

Catch your next role the second it’s posted.

Create a free account and we’ll watch the boards for you — the instant a job matches your search, it lands in your inbox or Telegram. No digging, no refreshing.

Create free account

Free forever · takes 30 seconds · already have one?

Ganhe vantagem na sua busca por emprego.

Entre no nosso canal do Telegram para o que ajuda você a conseguir a vaga — referências salariais, o pulso semanal do mercado e avisos de novos recursos. Sem spam, só sinal.

Entre no canal — é grátis